Armistice Capital »

Olb Group shares owned by Armistice Capital

Quarter-by-quarter ownership of Olb Group (OLB) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Olb Group

Tip: Access up to 7 years of quarterly data

All positions including Olb Group held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olb Group by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $583k 1.5M 0.38

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Olb Group

Armistice Capital
Citadel Advisors
Vanguard Capital Management
Virtu Financial
Geode Capital Management
Avalon Trust
Susquehanna International
Jane Street
IFP Advisors
Tower Research Capital
Marshall & Sterling Wealth Advisors
Morgan Stanley
SBI Securities

View all funds holding Olb Group